HOME >> BIOLOGY >> NEWS
Lung and bladder cancer deaths continue decades after arsenic exposure

Arsenic exposure appears to continue causing lung and bladder cancer deaths years after exposure ends, according to a study published online June 12 in the Journal of the National Cancer Institute.

Arsenic is a known cause of lung and bladder cancer, but researchers dont yet know how long cancer risk remains elevated after arsenic exposure. The drinking water in a region of northern Chile became contaminated with very high amounts of arsenic beginning in 1958. In the 1970s, construction of water treatment plants in the region led to a decline in arsenic concentration. This sudden rise and fall of arsenic levels gave researchers the opportunity to investigate the period between first and last exposure to high levels of arsenic and subsequent mortality due arsenic-related cancers, such as bladder and lung cancer.

Guillermo Marshall, Ph.D., of Pontificia Universidad Catlica de Chile in Santiago and colleagues including collaborators from the University of California, Berkeley, investigated bladder and lung cancer death rates in the region between 1950 and 2000 and compared them with data from a similar region farther south, where the water was not contaminated.

Lung and bladder cancer mortality rates in the area with arsenic-contaminated drinking water began to rise about 10 years after arsenic levels rose. They then continued to climb, peaking between 10 and 20 years after the arsenic levels dropped. At the peak, lung cancer deaths among men and women in the contaminated region were about three times higher than in the control region, while bladder cancer deaths were six times higher in men and 14 times higher in women. The lag time between exposure to a carcinogen and the peak of cancer deaths is usually difficult to determine, but the size of the study and the record of arsenic exposure aided the researchers.

The impact of arsenic in drinking water on this large population is without precedent for environmental cau
'"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
12-Jun-2007


Page: 1 2

Related biology news :

1. Scientists move closer to bio-engineered bladders
2. UF scientists work to develop simple bladder cancer test
3. Prevalence of overactive bladder is overestimated
4. Proteins effects essential for kidney-to-bladder urine transfer
5. Broccoli packs powerful punch to bladder cancer cells
6. Blocking PLK-1 to beat bladder cancer
7. New risks for bladder cancer identified by MIT team
8. Protein chatter linked to cancer activation
9. Newly created cancer stem cells could aid breast cancer research
10. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
11. ESF EURYI award winner aims to stop cancer cells reading their own DNA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
(Date:1/21/2017)... Research and Markets has announced the addition of the ... ... voice recognition biometrics market to grow at a CAGR of 19.36% ... present scenario and the growth prospects of the global voice recognition ... considers the revenue generated from the sales of voice recognition biometrics ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... , ... February 27, 2017 , ... The Catalyst ... a few in the Midwest offering premix services and private label organic services. , ... laying hens, according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical and ... previous two-year TDR studies. , Jake Lubinski, president of AxioMed, commented on ...
(Date:2/24/2017)... Tenn. , Feb. 24, 2017 ... ("Provectus" or the "Company"), a clinical-stage oncology and ... regarding the deadline to participate in its previously ... units, consisting of shares of common stock and ... and holders of listed warrants. ...
(Date:2/24/2017)... 24, 2017  Driven by consumers, preference towards ... the fastest growing categories, finds the recently published ... Personal Care: Multi-regional Market Analysis and Opportunities ... firm Kline. "Biotechnology actives are derived ... more effective for skin and hair care applications," ...
Breaking Biology Technology:
Cached News: